Cargando…
EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation
Ezrin-radixin-moesin-binding phosphoprotein-50 (EBP50) suppresses breast cancer cell proliferation, potentially through its regulatory effect on epidermal growth factor receptor (EGFR) signaling, although the mechanism by which this occurs remains unknown. Thus in our studies, we aimed to determine...
Autores principales: | Yao, Wenfang, Feng, Duiping, Bian, Weihua, Yang, Longyan, Li, Yang, Yang, Zhiyu, Xiong, Ying, Zheng, Junfang, Zhai, Renyou, He, Junqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472071/ https://www.ncbi.nlm.nih.gov/pubmed/22476347 http://dx.doi.org/10.1007/s00726-012-1277-z |
Ejemplares similares
-
Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma
por: Zheng, Junfang, et al.
Publicado: (2016) -
The scaffolding protein EBP50 regulates microvillar assembly in a phosphorylation-dependent manner
por: Garbett, Damien, et al.
Publicado: (2010) -
SMOC Binds to Pro-EGF, but Does Not Induce Erk Phosphorylation via the EGFR
por: Thomas, J. Terrig, et al.
Publicado: (2016) -
Ras-activated RSK1 phosphorylates EBP50 to regulate its nuclear localization and promote cell proliferation
por: Lim, HooiCheng, et al.
Publicado: (2016) -
EGF-dependent re-routing of vesicular recycling switches spontaneous phosphorylation suppression to EGFR signaling
por: Baumdick, Martin, et al.
Publicado: (2015)